Swedish Orphan Biovitrum Ltd

Active04369760ManufacturingIncorporated 8 Feb 2002 · Cambridge

The principal activity of the company is the marketing and selling of products used for the treatment of rare medical disorders.

Revenue

£88.7m

▲ +13.1% vs prior ~12m period

Profit after tax

£3.5m

Margin 4.5%

Employees

92

▲ +53.3% vs prior ~12m period

Net assets

£26.9m

Total assets £66.0m

Financial history

Revenue by accounting period

3 periods available · ▲ growth ▼ decline

Jan 2024
Not available
Dec 2024
£78.4m
Dec 2025
£88.7m▲ +13.1%
Period endRevenueGrowthProfit before taxEmployeesNet assets
31 Dec 2025£88.7m▲ +13.1%£4.4m92£26.9m
31 Dec 2024£78.4m—£6.0m60£23.6m
1 Jan 2024————£19.3m

Latest available figures

Period ending 31 Dec 2025. “Not available” means the figure is not in the accounts we hold. We do not estimate missing figures.

Profit & loss

Revenue
£88.7m
Gross profit
£22.1m
Operating profit
£4.0m
Profit before tax
£4.4m
Profit after tax
£3.5m

Balance sheet

Total assets
£66.0m
Cash
Not available
Total liabilities
£39.0m
Net assets
£26.9m
Revenue per employee
£964k

Similar companies

CompanyRevenueGrowth
Spirax Group PLC
00596337
£1.7bn▲ +2.3%
Ds Smith Packaging Limited
00630681
£687.2m▼ -9.8%
Kepak Group Limited
SC440783
£648.4m▲ +10.8%
Baird & Co. Limited
02269558
£471.1m▲ +25.5%
Bamford Bus Company Limited
12214576
£455.1m▲ +76.6%

Other manufacturing companies in East of England

CompanyRevenueGrowth
Direct Table Foods Limited
01816960
£143.3m▼ -12.3%
Ro-Ark Aerospace Limited
15319796
£143.2m▲ +288.1%
Mcmullen Facades Limited
11073163
£120.8m—
Chelmer Foods Limited
02704138
£112.2m▲ +4.1%
Dr Reddy'S Laboratories (UK) Limited
01729064
£95.0m▲ +41.0%